Clinigen supported a global mid-sized pharmaceutical company in streamlining its operations by divesting a portfolio of niche hospital products. The process involved ensuring regulatory compliance, managing risks, and maintaining supply continuity across multiple international markets.

Read the case study to learn how Clinigen’s comprehensive approach, including strategic regulatory submissions and proactive stakeholder coordination, facilitated a seamless transition which allowed the client to focus on core business activities while minimising delays and costs.